Thromboangiitis obliterans (TAO) is a nonatherosclerotic segmental inflammatory obliterative disease that most commonly affects the small- and medium-sized arteries and veins in both upper and lower extremities. In the past, TAO was exclusively a disease confined to men; however, recently more women have been diagnosed with TAO. Most patients are heavy users of tobacco, and usually cigarette smokers.
LieJ T. The rise and fall and resurgence of thromboangiitis obliterans (Buerger's disease). Acta Pathol Jpn1989; 39: 153–58.
5.
LieJ T. Thromboangiitis obliterans (Buerger's disease) in women. Medicine1987; 65: 65–72.
6.
OlinJ WYoungJ RGraorR ARuschhauptW FBartholomewJ R. The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease). Circulation1990; 82 (suppl IV): 3–8.
7.
MillsJ LPorterJ M. Buerger's disease: A review and update. Semin Vasc Surg1993; 6: 14–23.
8.
CachovanM. Epidemiologie und geographisches Verte-ilungsmuster der Thromboangiitis Obliterans. In HeidrichH ed. Thromboangiitis Obliterans Morbus Winiwarter–Buerger. Stuttgart, New York: George Thieme, 1988; 31–36.
9.
HillG LMoelionoJTumewuF. The Buerger syndrome in Java: A description of the clinical syndrome and some aspects of its aetiology. Br J Surg1973; 60: 606–613.
10.
PapaM ZAdarR. A critical look at thromboangiitis obliterans (Buerger's disease). Vasc Surg1992; 5: 1–21.
11.
HarkavyJ. Tobacco sensitivities in thromboangiitis obliterans, migratory phlebitis, and coronary artery disease. Bull N Y Acad Med1933; 9: 318–22.
12.
WestcottF NWrightI S. Tobacco allergy and thromboangiitis obliterans. J Allerg1938; 9: 555–64.
13.
GroveW JStansbyG P. Buerger's disease and cigarette smoking in Bangladesh. Ann Roy Coll Surg Engl1992; 74: 115–18.
14.
JindalR MPatelS M. Buerger's disease in cigarette smoking in Bangladesh. Ann Roy Coll Surg Engl1992; 74: 436–37.
15.
KjeldsenKMozesM. Buerger's disease in Israel. Investigators on carboxyhemoglobin and serum cholesterol levels after smoking. Acta Chir Scand1969; 135: 495–98.
16.
LieJ T. Thromboangiitis obliterans (Buerger's disease) in an elderly man after cessation of cigarette smoking – a case report. Angiology1987; 38: 864–67.
17.
LieJ T. Thromboangiitis obliterans (Buerger's disease) and smokeless tobacco. Arthritis Rheum1988; 31: 812–13.
18.
JoyceJ W. Buerger's disease (thromboangiitis obliterans). Rheum Dis Clin North Am1990; 116: 463–70.
19.
HadaMSakihamaTKamiyaKTasakaTUenoA. Cellular and humoral immune responses to vascular components in thromboangiitis obliterans. Angiology1993; 44: 533–40.
20.
AdarRPapaM CHalperinZ. Cellular sensitivity to collagen in thromboangiitis obliterans. N Engl J Med1983; 308: 1113–16.
21.
GulatiS MSahaKKantLThusooT KPrakashA. Significance of circulating immune complexes in thromboangiitis obliterans (Buerger's disease). Angiology1984; 35: 276–81.
22.
de AlbuquerqueRankin RDelgadoLCorrelaPTorrinhaJ FSerraoDBragaA. Circulating immune complexes in Buerger's disease. Endarteritis obliterans in young men. J Cardiovasc Surg1989; 30: 821–25.
23.
McLoughlinG AHelsbyC REvansC CChapmanD M. Association of HLA-A9 and HLA-B5 with Buerger's disease. BMJ1976; 2: 1165–66.
24.
NumanoFSasazukiTKoyamaT. HLA in Buerger's disease. Expl Clin Immunogenet1986; 3: 195–200.
MillsJ LTaylorL MJrPorterJ M. Buerger's disease in the modem era. Am J Surg1987; 154: 123–29.
27.
De MoerlooseP HJeannetMMirimanoffPBouvierC A. Evidence for an HLA-linked resistance gene in Buerger's disease. Tissue Antigens1979; 14: 169–73.
28.
CravenJ LCottonR C. Haematological differences between thromboangiitis obliterans and atherosclerosis. Br J Surg1967; 54: 862–67.
29.
ChaudhuryN APietraszekM HHachiyaT. Plasminogen activators and plasminogen activator inhibitor 1 before and after venous occlusion of the upper limb in thromboangiitis obliterans (Buerger's disease). Thromb Res1992; 66: 321–29.
30.
PietraszekM HChaudhuryN AKoyanoK. Enhanced platelet response to serotonin in Buerger's disease. Thromb Res1990; 60: 241–46.
31.
TakamiSKuboMYamashitaS. High levels of serum lipoprotein (a) in patients with ischemic heart disease with normal coronary angiogram and thromboangiitis obliterans. Atherosclerosis1995; 112: 253–60.
32.
Hofer-MayerTAdlerRMinderCMahlerFRadvilaA. Clinical speculation: Is specificity back? This time thromboangiitis obliterans. Psychosom Med1995; 57: 195–201.
33.
DibleJ H. The pathology of the limb ischemia. Edinburgh: Oliver and Boyd, 1966, 79–96.
LeuH J. Early inflammatory changes in thromboangiitis obliterans. Pathol Microbiol1975; 43: 151–56.
36.
LeuH J. Thromboangiitis obliterans Buerger. Schweiz Med Wschr1985; 115: 1080–86.
37.
LeuH JBollingerA. Phlebitis saltans sive migrans. Vasa1978; 7: 440–40.
38.
FleshL HKihmR HCiccioS S. Radionuclide imaging of aortic involvement in Buerger's disease: Case report. J Nucl Med1977; 18: 125–27.
39.
KorsagaardNJohansenABaaudrupU. A case of thromboangiitis obliterans affecting coronary, pulmonary and splenic vessels. Is thromboangiitis obliterans a generalized vascular disease?Am J Cardiovasc Pathol1988; 2: 263–67.
40.
ShionoyaSBanINakataY. Involvement of the iliac artery in Buerger's disease (pathogenesis and arterial reconstruction). J Cardiovasc Surg1978; 19: 69–76.
GomiTIkedaTYuharaM. Renovascular hypertension due to Buerger's disease. Jpn Heart J1978; 19: 308–14.
43.
DeitchE ASikkemaW W. Intestinal manifestation of Buerger's disease: Case report and literature review. Am Surg1981; 47: 326–28.
44.
SchellongS MBernhardsJEnsslenFSchaferH JAlexanderK. Intestinal type of thromboangiitis obliterans (Buerger's disease) [Review]. J Intern Med1994; 235: 69–73.
45.
LieJ T. Thromboangiitis obliterans (Buerger's disease) in a saphenous vein arterial graft. Hum Pathol1987; 18: 402–404.
46.
LieJ TMichetC JJr. Thromboangiitis obliterans with eosinophilia (Buerger's disease) of the temporal arteries. Hum Pathol1988; 19: 598–602.
47.
OlinJ WLieJ T. Thromboangiitis obliterans (Buerger's disease). In: CookeJ PFrohlichE D eds. Current management of hypertension and vascular disease. St Louis: Mosby Yearbook, 1992; 265–71.
48.
YamamotoKIwaseSManoTShionoyaS. Muscle sympathetic outflow in Buerger's disease. J Autonom Nerv Sys1993; 44: 67–76.
49.
McKusickV AHarrisW SOttsenO EGoodmanR M. The Buerger syndrome in the United States. Arteriographic observations with special reference to involvement of the upper extremities and the differentiation from atherosclerosis and embolism. Bull Johns Hopkins Hosp1962; 110: 145–76.
50.
McKusickV AHarrisW SOttsenO E. Buerger's disease: A distinct clinical and pathologic entity. JAMA1962; 181: 93–100.
51.
PapaM ZRabiIAdarR. A point scoring system for the clinical diagnosis of Buerger's disease. Eur J Vasc Endovasc Surg1996; 11: 335–39.
52.
GiffordR WHinesE A. Complete clinical remission in thromboangiitis obliterans during abstinence from tobacco: Report of a case. Proc Staff Meeting Mayo Clin1951; 26: 241–45.
53.
CorelliF. Buerger's disease: Cigarette smoker disease may always be cured by medical therapy alone. Uselessness of operative treatment. J Cardiovasc Surg1973; 14: 28–36.
54.
HusseinE ADorriA E. Intra-arterial streptokinase as adjuvant therapy for complicated Buerger's disease. Early trials. Internat Surg1993; 78: 54–58.
55.
FiessingerJ NSchaferM. Trial of Iloprost vs aspirin. Treatment for critical limb ischemia of thromboangiitis obliterans. Lancet1990; 335: 555–57.
56.
InadaKIwashimaYOkadaAMatsumotoK. Non-atherosclerotic segmental arterial occlusion of the extremities. Arch Surg1974; 108: 663–67.
